Immunoglobulin E specific to Tetracoccosporium paxianum antigens (sIgE (Tetracoccosporium paxianum))

Immunoglobulin E (IgE) antibodies specific to Tetracoccosporium paxianum antigens are key immunological mediators that drive allergic reactions to this specific environmental fungus. Tetracoccosporium paxianum is a dematiaceous mold found in soil and organic debris, and its airborne spores are recognized as potent allergens in sensitized individuals (Simon-Nobbe et al., 2008). These specific IgE antibodies circulate in the blood and bind to high-affinity FcεRI receptors on the surface of mast cells and basophils. When the individual is re-exposed to Tetracoccosporium paxianum antigens, the antigens cross-link the bound IgE molecules, triggering the immediate release of inflammatory mediators such as histamine and leukotrienes (NCBI, 2023). This cascade leads to the clinical manifestations of Type I hypersensitivity, including allergic rhinitis, conjunctivitis, and asthma. While therapeutic agents like omalizumab target the entire IgE class to prevent these interactions, the measurement of specific IgE levels remains a gold standard for diagnosing fungal sensitization (Thermo Fisher Scientific, 2024). Understanding the role of these antibodies is crucial for managing fungal-related respiratory diseases and developing targeted immunotherapy.

Other names

Anti-Tetracoccosporium paxianum IgETetracoccosporium paxianum-specific IgEm211-specific IgE

Inhibition of IgE binding to the high-affinity FcεRI receptor on mast cells and basophils.